Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Randomized Phase II Trial of Belinostat (PXD101) in Combination With Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Previously Untreated Carcinoma of Unknown Primary

NCT00873119 is registered in ClinicalTrials.gov with Valerio Therapeutics as lead sponsor.

NCT NCT00873119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00873119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Randomized Phase II Trial of Belinostat (PXD101) in Combination With Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Previously Untreated Carcinoma of Unknown Primary
Lead sponsor
Valerio Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2009
Completion date
December 31, 2012
Enrollment
89 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma of unknown primary